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Abstract
AIM: To explore whether predisposition to autoimmune 
gastritis (AIG) is found in human leukocyte antigen (HLA), 
cytokine or killer cell immunoglobulin-like receptor (KIR) 
gene variations. 
METHODS: Twelve Finnish patients with autoimmune-
type severe atrophy of the gastric corpus were included. 
The patients’ serum was analyzed for pepsinogen Ⅰ and 
Helicobacter pylori (H. pylori ) antibodies. DNA was 
separated and the patients were genotyped for HLA-A, 
B, Cw, DRB1 and DQB1 antigens, and studied for single 
nucleotide polymorphisms for the following cytokines: 
interleukin (IL)-1 gene cluster, IL-2, IL-4, IL-6, IL-10, 
IL-12, interferon γ, transforming growth factor β, and 
tumor necrosis factor α. Variation in KIR genes was also 
explored. The results were compared with prevalence of 
the polymorphisms in Finnish or European populations. 
RESULTS: All patients had pepsinogen Ⅰ levels below 
normal (mean: 11 µg/L, range: < 5 to 25 µg/L). Three 
patients had elevated H. pylori IgG antibodies, while 
H. pylori  serology was negative in the rest of the patients. 
AIG patients carried significantly more often HLA-
DRB1*04 (58%) and DQB1*03 (83%) than the general 
Finnish population did (28% and 51%, respectively; P = 
0.045 and 0.034 by the Fisher’s exact test). No patient 
was positive for HLA-B8-DRB1*03, a well-established 
autoimmune marker. Neither cytokine polymorphisms nor 
KIR gene variation showed association with AIG. 
CONCLUSION: As explored with modern DNA-based 
methods, HLA-DRB1*04 and DQB1*03 alleles, but not 
HLA-B8-DRB1*03, may predispose to AIG.
© 2010 Baishideng. All rights reserved.
Key words: Atrophic gastritis; Autoimmune diseases; 
Cytokines; Genetic polymorphisms; Human leukocyte 
antigens; Killer cell immunoglobulin-like receptor
Peer reviewers: David J McGee, PhD, Associate Professor, 
Department of Microbiology & Immunology, Louisiana State 
University Health Sciences Center-Shreveport, 1501 Kings 
Highway, Shreveport, LA 71130, United States; Tamara 
Vorobjova, Senior Researcher in Immunology, Department of 
Immunology, Institute of General and Molecular Pathology, 
University of Tartu, Ravila, 19, Tartu, 51014, Estonia, Tamara
Oksanen AM, Haimila KE, Rautelin HIK, Partanen JA. 
Immunogenetic characteristics of patients with autoimmune 
gastritis. World J Gastroenterol 2010; 16(3): 354-358  Available 
from: URL: http://www.wjgnet.com/1007-9327/full/v16/i3/
354.htm  DOI: http://dx.doi.org/10.3748/wjg.v16.i3.354
Oksanen AM et al . Immunogenetics of autoimmune gastritis
355 January 21, 2010|Volume 16|Issue 3|WJG|www.wjgnet.com
INTRODUCTION 
Autoimmune gastritis (AIG) is an organ-specific auto-
immune disease, in which inflammation of  the mucosa 
of  the gastric corpus results in total loss of  corpus-type 
glands, and achlorhydria. AIG patients typically have a 
low serum pepsinogen Ⅰ (PG Ⅰ) concentration, and 
most of  them also have parietal cell antibodies (PCAs). 
In many, but not all patients, vitamin B12 absorption is 
deficient, which leads to pernicious anemia (PA)[1]. 
The occurrence of  AIG and PA has long been recog-
nized to be determined strongly by genetic factors, which, 
however, are largely unexplored. The most important 
genetic association found in human AIG so far is a link 
with the human leukocyte antigen (HLA) region. The 
observed association between AIG and certain HLA 
antigens has, however, not been strong enough to explain 
the familial clustering of  AIG[2].
Polymorphisms in the genes that encode immune 
regulator molecules may affect the secretion or function 
of  the corresponding proteins, and thus influence 
immune responses, inflammation and tissue injury. 
Cytokine genes have been studied widely in autoimmune 
diseases and associations have been found between, for 
instance, tumor necrosis factor α (TNFα) and interleukin 
(IL)-10 polymorphisms and autoimmune hepatitis 
and pemphigus, respectively[3,4]. Also Helicobacter-pylori 
(H. pylori)-associated atrophic gastritis has been shown 
to be more frequent in patients with proinflammatory 
polymorphisms of  genes for IL-1 gene cluster, and 
TNFα[5]. 
Killer cell immunoglobulin-like receptors (KIRs) are 
members of  a diverse family of  regulatory molecules 
expressed on subsets of  T cells. KIRs play a role in 
the control of  the natural killer (NK) cell immune 
response. The KIR receptors recognize certain HLA 
class Ⅰ determinants and regulate NK cell activity. The 
number and type of  KIR genes vary between individuals 
who can carry anything from seven to 12 KIR genes, 
of  which, some encode activating and others inhibiting 
receptors[6,7]. KIR genes can be divided into two main 
haplotype groups. Group A contains only one activating 
and six inhibiting KIR genes, whereas group B haplotypes 
are more variable and contain several activating KIR 
genes[8]. In addition to the copy-number variation, 
individual KIR genes exhibit allelic variation. KIR genes 
have been shown to be associated with various diseases, 
including some autoimmune diseases[9].
Recently, we sequenced the coding regions of  genes 
for α- and β-subunits of  H+/K+-ATPase, which is 
the main autoantigen in AIG, in AIG patients, but no 
disease-associated polymorphisms could be found[10]. 
In the present study, a number of  genes involved in 
immune activation were explored in patients with AIG, 
by modern molecular genetic methods. The aim of  
this study was to determine whether variations in the 
immune regulator genes, such as HLA, cytokine or KIR, 
are associated with the presence of  AIG. 
MATERIALS AND METHODS
Clinical information
A total of  18 patients, who had earlier undergone 
gastroscopy at Herttoniemi Hospital and were known to 
have severe atrophic corpus gastritis without any history 
of  H. pylori infection, and who were under 65 years of  
age, were invited by letter to participate in the study. 
Twelve patients gave written informed consent, donated a 
blood sample, and completed a questionnaire about their 
possible vitamin B12 replacement therapy and thyroid 
diseases, as well as the occurrence of  AIG in the family. 
Signs of  other autoimmune diseases were looked for in 
the patient records. The study was approved by the Ethical 
Committee for Internal Medicine at Helsinki University 
Central Hospital.
Blood tests
EDTA blood and serum samples were kept at -20℃ 
until analyzed. DNA was extracted from the EDTA 
blood sample using a DNA purification kit (PureGene®; 
Centrasystems, Minneapolis, MN, USA), according to the 
manufacturer’s instructions. Serum samples were analysed 
for PG Ⅰ , PCAs and H. pylori antibodies.
For serum PG Ⅰ concentrations, an immunoenzy-
mometric assay (Gastroset PG1; Orion Diagnostica, Espoo, 
Finland) was used. The lower normal limit of  the assay was 
28 µg/L. PCAs were determined by an enzyme immunoassay 
(Varelisa Parietal Cell Antibodies; Pharmacia Diagnostics, 
Freiburg, Germany), which used H+/K+-ATPase as the 
antigen. Concentrations < 10 U/mL were normal, according 
to the manufacturer. For H. pylori antibodies, an in-house 
immunoassay that measured IgG antibodies was used, and 
titers ≥ 700 were considered elevated[11].
Immunogenetics
HLA genes were explored using the INNO-LiPA 
kit (Innogenetics, Ghent, Belgium) according to the 
manufacturer’s instructions. The HLA-A, B, Cw, DRB1 
and DQB1 genes were amplified by polymerase chain 
reaction (PCR), and the biotinylated PCR products were 
hybridized with sequence-specific oligonucleotides on 
membrane-based strips. Results were analyzed by the 
LiRAS (Innogenetics) interpretation software.
Cytokine polymorphisms in the genes of  IL-1 gene 
cluster, IL-2, IL-4, IL-6, IL-10, IL-12, interferon (IFN)-γ, 
transforming growth factor (TGF) β, and TNFα were 
genotyped using the Cytokine Genotyping Kit (Pel-
Freez Clinical Systems, Brown Deer, WI, USA). Cytokine 
profiles (high/intermediate/low producer) based on the 
polymorphisms were formed according to the published 
phenotypes also mentioned in the product insert of  the kit. 
KIR genes (KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL4, 
KIR2DL5, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, 
KIR2DS5, KIR3DL1, KIR3DL2, KIR3DL3, KIR3DS1, 
KIR2DP1 and KIR3DP1) were determined using the KIR 
Genotyping Kit (Pel-Freez Clinical Systems), following 
the manufacturer’s instructions. Both genotyping kits were 
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based on PCR amplification with sequence-specific primers 
that were designed to detect polymorphisms of  cytokine/
KIR genes. The PCR products were separated by gel 
electrophoresis, and the genotype results were interpreted 
on the basis of  specific amplification patterns.
Prevalence of  the HLA genotypes was compared 
with HLA frequency in the Finnish population, based 
on the data collected in Clinical Laboratory of  Finnish 
Red Cross blood service. The cytokine polymorphisms 
and KIR genes were compared with the frequency of  
polymorphisms and KIR genes in populations of  Finnish 
of  European ancestry published previously[12-15]. 
Statistical analysis
Fisher’s exact test was used to compare the prevalence 
of  genotypes between patients and the populations used 
as controls.
RESULTS
Demographic and clinical characteristics of  the patients 
are summarized in Table 1. All patients had total atrophy in 
the gastric corpus. The mucosa of  the gastric antrum was 
normal in eight patients, and mild chronic inflammation or 
sparse intestinal metaplasia was detected in four. All patients 
had PG I levels below normal (mean: 11 µg/L, range: < 
5 to 22 µg/L), and elevated PCAs (median: 185 U/mL, 
range: 20-509 U/mL). Three patients (numbers 3, 10 and 
11 in Tables 1 and 2) had elevated H. pylori IgG antibodies 
(titers: 730-2200), whereas H. pylori serology was entirely 
negative in the rest of  the patients (titers: 50-100). All 
patients but one (number 2 in Tables 1 and 2) had vitamin 
B12 replacement therapy.
Immunogenetics of the patients
The HLA-A, B, Cw, DRB1 and DQB1 alleles in the AIG 
patients are shown in Table 2. DRB1*04 was present 
in seven out of  12 (58%) patients, whereas 28% of  the 
Finnish general population carry the allele (P = 0.045 by 
Fisher’s exact test). Ten patients (83%) had DQB1*03; 
its allele frequency in the Finnish population is 51% (P = 
0.034 by Fisher’s exact test). 
Only one of  the 12 patients carried the DRB1*0301-
DQB1*0201 haplotype, which is an establ ished 
susceptibility factor for various autoimmune diseases[16]. 
It is of  particular note that the only DRB1*0301-positive 
patient did not have the classical A*01-B*08 haplotype. 
The frequencies of  polymorphisms in the genes of  
the IL-1 gene cluster, IL-2, IL-4, IL-6, IL-10, IL-12, IFNγ, 
TGFβ and TNFα did not differ significantly from those 
found in Finnish (where data were available) or other 
European populations. The results for genotyping the 
IL-1 gene cluster, TNFα and IL-10 are shown in Table 3.  
All 14 characterized KIR genes, KIR2DL1, KIR2DL2, 
KIR2DL3, KIR2DL4, KIR2DL5, KIR2DS1, KIR2DS2, 
KIR2DS3, KIR2DS4, KIR2DS5, KIR3DL1, KIR3DL2, 
KIR3DL3 and KIR3DS1, were determined, as well as two 
KIR pseudogenes KIR2DP1 and KIR3DP1. Ten patients 
carried both A and B KIR haplotypes; two patients 
were homozygotes for A haplotype. KIR genotype and 
haplotype frequencies of  the patients did not differ from 
those reported earlier in the Finnish population[15].
DISCUSSION 
In Finnish AIG patients, the HLA-DRB1*04 and 
DQB1*03 alleles were more frequent than in the general 
population, which implies an association between certain 
HLA-DRB1 and DQB1 haplotypes and AIG. The well-
known autoimmune markers HLA-B8, DRB1*03 and 
DQB1*02 were practically missing in the AIG patients. 
This suggests that the immunogenetics of  AIG are 
different to that of  many classical autoimmune diseases. 
The co-localization of  susceptibility foci in experimental 
AIG and type 1 diabetes (T1D) is the strongest known 
between two autoimmune diseases[2], and the most prominent 
susceptibility locus for both diseases is located in the HLA 
region. Individuals with T1D also have PCAs more often 
than population controls do[17]. Over 90% of  Caucasians with 
T1D carry the DR3 or DR4 haplotype, and the DQB1*0302 
allele is associated strongly with T1D[18]. In the present study, 
the DRB1*04 allele was more frequent in AIG patients 
Table 1  Clinical characteristics of the 12 AIG patients
Patient Sex Age 
(yr)
Years from  
diagnosis
Other autoimmune 
diseases
AIG 
in family
1 F 50   7 -
2 F 56   3 RA +
3 F 49   2 +
4 M 62 19 +
5 F 63   2 HT +
6 F 54   3 -
7 F 38   4 +
8 F 56   5 PBC -
9 F 52   0 -
10 F 52   0 -
11 F 47 15 T1D -
12 F 52   0 -
AIG: Autoimmune gastritis; RA: Rheumatoid arthritis; HT: Hyperthyreosis; 
PBC: Primary biliary cirrhosis; T1D: Type 1 diabetes.
Table 2  HLA-A, B, Cw, DRB1 and DQB1 genotypes of the 
12 AIG patients
Patient HLA-A HLA-B HLA-Cw HLA-DRB1 HLA-DQB1
1 03 11 07 44 01 07 12 15 0301 0602
2 02 - 15 51 04 14 04 08 0302 0402
3 02 24 15 39 04 07 04 15 0302 0602
4 02 03 07 18 07 - 04 15 0302 0602
5 02 26 15 40 03 04 01 08 0402 0501
6 02 03 15 - 03 - 04 08 0302 0402
7 02 - 13 51 06 15 07 09 0202 0303
8 02 32 40 51 02 15 09 15 0303 0602
9 03 - 07 51 03 15 04 13 0301 0303
10 02 03 35 40 04 07 04 12 0301 0302
11 02 - 27 35 01 03 03 08 0201 0402
12 03 24 13 35 04 06 04 - 0302 -
Oksanen AM et al . Immunogenetics of autoimmune gastritis
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than in the general population, but the DRB1*03 allele was 
only carried by the patient with T1D. Six of  our 12 patients 
had DQB1*0302, the prevalence of  which in the Finnish 
population is 13% (P = 0.005 by Fischer’s exact test). The 
AIG patient with T1D was also the only one to carry the 
DQB1*02 haplotype, which is present in 91% of  Finnish 
celiac disease patients[19], and in 17% of  the general Finnish 
population. Thus, Finnish AIG patients seem to share some 
of  the haplotypes that are common in patients with T1D, but 
not those seen in patients with celiac disease. 
In the 1970s, several studies were carried out to find 
a possible association between AIG or PA and HLA 
antigens. Increased frequency of  HLA antigens A3, B7 
or both has been found in AIG and PA patients[20-22]; 
however, these findings were not confirmed by others[23]. 
Subgroups of  AIG patients have shown associations 
with different HLA antigens. Patients with a concomitant 
endocrine disease showed an increased frequency of  the 
B8, B18 and BW15 antigens, and those without endocrine 
disease that of  the B7 and B12 antigens[24].
Of  the class II HLA antigens, PA patients showed 
increased frequency of  the DR2 and DR4 antigens and a 
decreased presence of  the DR3 antigen, as compared to 
controls. PA patients with a concomitant endocrine disease 
showed DR3/DR4 antigens more often, and those without 
autoimmune endocrine disease showed DR2/DR4 and 
DR4/DR5 antigens, as compared to controls[25]. Possibly 
because of  the small number of  patients in the present 
study, no significant difference could be found between 
those with and without concomitant autoimmune disease. 
The role of  H. pylori in AIG and PA is still poorly 
understood[26]. On one hand, patients with H. pylori infection 
often develop atrophic gastritis and even autoimmune 
characteristics, such as PCAs[27]. On the other hand, AIG 
patients without any signs of  H. pylori infection, such as the 
majority of  patients in the present study, may be found. 
In studies before the Helicobacter era, the role of  H. pylori 
in atrophic gastritis was not recognized, and patients with 
Table 3  IL-1, IL-10, and TNFα polymorphisms in 12 AIG 
patients, and in Finnish, Italian and Czech populations
 
Genotype AIG 
patients
Finnish[11] 
%
Italian[12]  
%
Czech[13] 
%
TNFα-308 AA1 -   3   2   2
GA - 21 14 38
GG       12 76 84 60
IL-1β-511 TT1 -    9 10
CT 8  41 45
CC 4  50 45
IL1RA 
mspa111100
CC1 1   3   8
TC 8 41 45
TT 3 56 47
IL-10 ATA/ATA1 1   5  
ATA/ACC 1 21  
ACC/ACC 1   7  
GCC/ATA 5 24  
GCC/ACC 4 31  
GCC/GCC - 12  
1The genotypes are the most proinflammatory ones.
H. pylori-associated autoimmunity may have been included; 
this may have made it more difficult to detect associations 
between AIG and, for example, HLA antigens. Our patients 
were relatively young with a median age of  52 years and the 
majority were women, which is typical for the classic AIG[1]. 
The three patients with positive H. pylori serology showed 
no clinical difference from the others.
In H. pylori-positive individuals, proinflammatory 
polymorphisms of  the IL-1β  gene cluster have been found 
to be associated with atrophic gastritis, achlorhydria[28,29], 
and even gastric cancer[30], which often is a late sequel of  
atrophic gastritis. Patients carrying proinflammatory IL-
1β-511T and TNFα-308A, and who are homozygous for 
IL-1RN*2*2, had an OR of  5.8 for developing atrophic 
gastritis[31]. In addition, patients that carried three or more 
of  the proinflammatory polymorphisms (carriage of  IL-
1β-511T+ or TNFα -308A; homozygosity for IL-1RN*2*2 
or IL-10 ATA/ATA) had an OR of  26.3 for non-cardia 
gastric cancer[32]. However, the association between gastric 
cancer and IL-1β polymorphisms has not been seen in 
all studies[33]. Despite the fact that all our patients had 
profound atrophy in the gastric corpus at a relatively young 
age, the frequencies of  these particular genotypes did not 
differ from those found in populations with European 
ancestry. Even though the small number of  patients and the 
lack of  controls in the present study make it impossible to 
detect small or modest associations, our results suggest that 
these polymorphisms are not crucial for the development 
of  AIG.
In conclusion, HLA DRB1*04 and DQB1*03 were 
more frequent in AIG patients than in the general Finnish 
population, which suggests an association between certain 
HLA-DRB1 and DQB1 haplotypes and AIG. Also, the 
well-known autoimmune markers HLA-B8, DRB1*03 and 
DQB1*02 were practically missing in the AIG patients. 
However the number of  patients in the present study 
was small, and larger studies are needed to confirm these 
findings. 
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